![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Hypophosphatemia, Familial - 22 Studies Found
Completed |
: Effectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in X-linked Hypophosphatemic Rickets :
: 2006-12-28 :
|
Active, not recruiting |
: Hypophosphatemic Rickets in Norway :
|
Completed |
: Effect of Dietary Protein Source on Phosphaturia, PTH and FGF23 in Patients With CKD 3 and 4 : Chronic Kidney Disease : 2008-10-01 :
|
Recruiting |
: Efficacy and Safety of KRN23 Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With X Linked Hypophosphatemia (XLH) : X-Linked Hypophosphatemia : 2016-05-23 :
|
Active, not recruiting |
: Study of the Safety, Pharmacodynamics and Efficacy of KRN23 in Children From 1 to 4 Years Old With X-linked Hypophosphatemia (XLH) : X-Linked Hypophosphatemia : 2015-12-06 : Drug: KRN23 |
Completed |
: Growth Hormone Treatment in Children With Hypophosphatemic Rickets : X Linked Hypophosphatemic Rickets : 2016-03-15 : Drug: norditropine simplex Other Name: growth hormone |
Active, not recruiting |
: Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH) : X-linked Hypophosphatemia : 2015-08-25 : Biological: KRN23 KRN23 is a recombinant human immunoglobulin G isotype 1 (IgG1) monoclonal antibody (mA |
Active, not recruiting |
: Study of KRN23 in Adults With X-linked Hypophosphatemia (XLH) : X-linked Hypophosphatemia : 2015-07-17 :
|
Enrolling by invitation |
: Long-Term Extension Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia (XLH) : X-Linked Hypophosphatemia : 2014-12-03 : Drug: KRN23 KRN23 is a recombinant fully human immunoglobulin G1 (IgG1) monoclonal antibody (mAb) that b |
Recruiting |
: Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project. : : 2024-09-07 |